1. Home
  2. DARE vs FPAY Comparison

DARE vs FPAY Comparison

Compare DARE & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • FPAY
  • Stock Information
  • Founded
  • DARE 2015
  • FPAY 2003
  • Country
  • DARE United States
  • FPAY United States
  • Employees
  • DARE N/A
  • FPAY N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • FPAY Diversified Commercial Services
  • Sector
  • DARE Health Care
  • FPAY Consumer Discretionary
  • Exchange
  • DARE Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • DARE 26.3M
  • FPAY 27.2M
  • IPO Year
  • DARE N/A
  • FPAY N/A
  • Fundamental
  • Price
  • DARE $2.83
  • FPAY $1.06
  • Analyst Decision
  • DARE Strong Buy
  • FPAY Strong Buy
  • Analyst Count
  • DARE 3
  • FPAY 2
  • Target Price
  • DARE $12.50
  • FPAY $3.25
  • AVG Volume (30 Days)
  • DARE 4.3M
  • FPAY 86.9K
  • Earning Date
  • DARE 08-11-2025
  • FPAY 08-05-2025
  • Dividend Yield
  • DARE N/A
  • FPAY N/A
  • EPS Growth
  • DARE N/A
  • FPAY N/A
  • EPS
  • DARE N/A
  • FPAY N/A
  • Revenue
  • DARE $25,909.00
  • FPAY $139,800,732.00
  • Revenue This Year
  • DARE $99,756.91
  • FPAY $16.58
  • Revenue Next Year
  • DARE $119.77
  • FPAY N/A
  • P/E Ratio
  • DARE N/A
  • FPAY N/A
  • Revenue Growth
  • DARE N/A
  • FPAY 19.51
  • 52 Week Low
  • DARE $2.11
  • FPAY $0.84
  • 52 Week High
  • DARE $9.19
  • FPAY $2.37
  • Technical
  • Relative Strength Index (RSI)
  • DARE 64.97
  • FPAY 37.74
  • Support Level
  • DARE $2.11
  • FPAY $0.84
  • Resistance Level
  • DARE $9.19
  • FPAY $1.15
  • Average True Range (ATR)
  • DARE 0.57
  • FPAY 0.08
  • MACD
  • DARE 0.07
  • FPAY -0.01
  • Stochastic Oscillator
  • DARE 13.49
  • FPAY 46.34

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: